It is important to highlight that the association we found was slightly close to the level of significance and it merits careful attention, given that in the competing risk analysis, we did not find such a relationship.
← all excerpts
CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study).
1
—
—